Clover Health Investments Crop. ($CLOV) Stock Forecast: Up 5.3% Today

What is Clover Health Investments Crop.?

Clover Health Investments Corp (CLOV) is a healthcare technology company that focuses on improving health outcomes for seniors. Today, CLOV experienced a strong bullish movement in the stock market.

Why is Clover Health Investments Crop. going up?

CLOV stock is up 5.3% on Apr 13, 2026 16:50

• The bullish movement in CLOV's stock could be attributed to the positive sentiment generated by recent filings of beneficial ownership by key executives, including the VP of Finance, interim CFO, and CEO of Medicare Advantage.
• Disclosure of significant share ownership and RSUs by these executives indicates their confidence in the company's future performance, likely appealing to investors.
• The CEO of Medicare Advantage using vested shares to cover tax obligations demonstrates commitment to long-term growth, which could enhance investor trust and optimism in CLOV's prospects.
• The various ownership disclosures and transactions by key executives at Clover Health Investments probably played a role in today's bullish movement in CLOV's stock.

CLOV Price Chart

CLOV Technical Analysis

CLOV News

Clover Health (CLOV) finance VP reports 311,169 unvested RSUs in Form 3

Joseph Frank Oldakowski, VP of Finance and Controller at Clover Health Investments, Corp. (CLOV), has filed an initial ownership report (Form 3) disclosing beneficial ownership of 311,169 shares of Class A common stock. These shares are part of unvested time-based restricted stock units granted on June 16, 2025, and December 19, 2025, and represent equity-based compensation rather than open-market transactions. The filing clarifies that this is an initial statement of ownership, not a buy or sell transaction.

https://www.stocktitan.net/sec-filings/CLOV/form-3-clover-health-investments-corp-de-initial-statement-of-benefic-167ad3221b0b.html

Clover Health (CLOV) interim CFO discloses 1.24M-share ownership including RSUs

Clover Health Investments (CLOV) interim CFO Joseph Clay Thornton reported a beneficial ownership of 1,238,684 shares of Class A common stock in an amended Form 3. This total includes 912,860 shares from unvested time-based restricted stock unit awards. The filing clarifies his total equity exposure with the company, dating back to RSU grants in 2024 and 2025.

https://www.stocktitan.net/sec-filings/CLOV/form-3-a-clover-health-investments-corp-de-amended-initial-statement--55d659470f44.html

Clover Health (CLOV) interim CFO discloses 1.24M shares, 912k RSUs on Form 3

Clover Health Investments' interim CFO, Joseph Clay, has filed a Form 3 disclosing his initial beneficial ownership in the company. The filing indicates that Clay holds 1,238,684 shares of Class A common stock, which includes 912,860 shares underlying unvested Restricted Stock Unit (RSU) awards granted on February 16, 2024, October 15, 2024, and December 19, 2025. This Form 3 establishes his baseline equity position as an officer of Clover Health.

https://www.stocktitan.net/sec-filings/CLOV/form-3-clover-health-investments-corp-de-initial-statement-of-benefic-fff4f30fc760.html

Clover Health (CLOV) exec uses 6,197 vested shares for taxes

Clover Health Investments CEO of Medicare Advantage, Jamie L. Reynoso, had 6,197 shares of Class A Common Stock withheld on April 3, 2026, to cover tax obligations. This withholding was due to the vesting of 6.25% of restricted stock units granted on January 3, 2023. Following this transaction, Reynoso directly holds 2,869,922 shares of Class A Common Stock, with remaining RSUs vesting in quarterly installments until January 2027.

https://www.stocktitan.net/sec-filings/CLOV/form-4-clover-health-investments-corp-de-insider-trading-activity-bb8f7b0c5c8a.html

Trending Today

Instacart (Maplebear Inc) ($CART) Stock Forecast: Up 5.4% Today

Credo Technology Group ($CRDO) Stock Forecast: Up 5.4% Today

Teladoc Health Inc. ($TDOC) Stock Forecast: Up 5.2% Today

Power Integrations Inc. ($POWI) Stock Forecast: Up 5.3% Today

Whirlpool Corporation ($WHR) Stock Forecast: Up 5.1% Today

Sirius XM Holdings Inc. ($SIRI) Stock Forecast: Up 5.0% Today

Hims & Hers Health Inc. ($HIMS) Stock Forecast: Up 6.5% Today

Groupon Inc. ($GRPN) Stock Forecast: Up 5.1% Today

Avis Budget Group Inc. ($CAR) Stock Forecast: Up 14.0% Today

The Trade Desk Inc ($TTD) Stock Forecast: Up 5.9% Today

Clover Health Investments Crop. Price History

02.03.2026 - CLOV Stock was up 6.0%

• The rise in CLOV stock today could be linked to the announcement of an upcoming CFO transition. Despite this change, the company reiterated its financial outlook for 2026, which likely boosted investor confidence in its strategy and financial health.
• Although Vanguard reported holding zero shares in Clover Health, causing initial concerns, the market sentiment appeared to shift positively due to the company's reaffirmed financial guidance and growth prospects.
• An AI Analyst rated CLOV stock as Neutral citing a mix of financial quality and technical pressures, which may have dampened some market enthusiasm. However, the focus on membership growth and profitability goals likely balanced this, contributing to the observed bullish trend.

18.02.2026 - CLOV Stock was down 5.1%

• Executives at Clover Health, including Jamie L. Reynoso and Conrad Wai, had shares withheld to cover tax obligations related to vested restricted stock units (RSUs).
• The automatic withholding of shares for tax purposes may have led to increased selling pressure on the stock, contributing to the bearish movement.
• Investors might interpret the executives' actions as a lack of confidence in the company's future performance, further dampening market sentiment towards Clover Health.
• The series of tax-related share withholdings could have signaled potential concerns about the company's financial health or regulatory challenges, prompting investors to react bearishly.

23.09.2025 - CLOV Stock was up 5.5%

• Participation in a global healthcare conference suggests potential positive developments or strategic partnerships for Clover Health.
• Investors may interpret the conference participation as a signal of industry recognition and future growth prospects for the company.
• The rise in CLOV's stock price could be linked to increased investor confidence after the announcement of the CFO's presentation at the conference.
• Market participants could be expecting favorable insights or announcements during the conference, leading to a surge in CLOV's stock price.

05.10.2025 - CLOV Stock was down 27.8%

• The bearish movement in CLOV could be attributed to the disappointing earnings report for Q3, with the company reporting break-even earnings and missing revenue expectations.
• Investors might be concerned about the company's future growth prospects, as indicated by the negative earnings surprise.
• The market reaction could also reflect uncertainty about Clover Health Investments' ability to maintain its competitive edge in the healthcare technology sector.
• Overall, the bearish trend in CLOV today could be a result of investors reevaluating the stock's valuation in light of the underwhelming financial performance in the recent quarter.

22.00.2026 - CLOV Stock was up 5.3%

• The rise in CLOV stock could be linked to the CEO's recent share sales, potentially indicating confidence in the company's future.
• Upbeat forecasts for profitability in 2026 and an annual increase in Medicare Advantage membership likely boosted investor confidence and led to the stock's upward movement.
• Despite a lack of profitability over the past year, the expectation of turning profitable this year and being deemed slightly undervalued by InvestingPro could have additionally stimulated investor interest in CLOV.

04.02.2026 - CLOV Stock was up 6.8%

• The company recorded remarkable 40% revenue growth in 2025, hitting $1.9 billion, and saw a 38% increase in its Medicare Advantage membership to 113,803. This strong financial performance likely influenced the stock's positive movement.
• Despite reporting a GAAP net loss in 2025, Clover Health achieved non-GAAP profitability, indicating effective operational practices and cost control measures.
• Clover Health's forecast of achieving GAAP net income profitability in 2026, coupled with revenue guidance ranging between $2.81 billion and $2.92 billion, presented a promising future for investors, driving bullish sentiment in the market.
• The company's strategic efforts, including enhancements to its Clover Assistant platform, expansion into new regions, and introduction of new products, showcase its dedication to growth and innovation, further enhancing investor trust in the stock.

06.10.2025 - CLOV Stock was down 7.2%

• Highlighting CLOV as a great choice for value investors due to recent strong momentum and reasonable prices might have attracted a lot of attention and buying interest.
• Break-even earnings for Q3 with negative surprises on earnings and positive surprises on revenue could have led to disappointment among investors, causing a sell-off and contributing to the bearish movement.
• Mixed signals from market participants, expecting momentum but receiving disappointing earnings clues, likely resulted in increased volatility and downward pressure on CLOV's stock price.

05.02.2026 - CLOV Stock was down 6.7%

• Today's downturn in Clover Health's stock (CLOV) can be linked to various factors:
• Strong revenue growth and an increase in Medicare Advantage membership were overshadowed by higher net losses and loss per share in the recent SEC 10-K filing, causing concerns among investors about the company's profitability.
• The company's aim to reach GAAP profitability by 2026, while making progress in non-GAAP profitability, has raised doubts about its financial targets.
• Efforts to expand product offerings and geographic reach, as outlined in the Form 10-K, may result in higher operating expenses and competitive challenges, prompting investor wariness.
• General market volatility in the healthcare sector or broader market conditions could have influenced market sentiment, leading some investors to approach Clover Health's stock with more caution.

06.03.2026 - CLOV Stock was up 5.3%

• The bullish movement in CLOV stock could be attributed to the positive sentiment generated by executives receiving significant RSU grants, indicating confidence in the company's future performance and growth prospects.
• The announcement of the CFO transition and the reaffirmation of the 2026 financial outlook might have also contributed to investor optimism, showcasing stability and strategic planning within the company.
• The consistent vesting schedule of RSUs for key executives like Brady Patrick Priest, Karen Soares, Jamie L. Reynoso, and Wai Conrad, highlights a long-term commitment to the company's success, instilling trust among shareholders and potential investors.
• Overall, these developments suggest a positive outlook for Clover Health, reinforcing investor confidence and driving the bullish movement in CLOV stock.

03.01.2026 - CLOV Stock was down 5.6%

• The bearish movement in CLOV stock today may be linked to the upcoming release of its fourth quarter and full year 2025 financial results. Investors seem cautious about the company's performance, resulting in a sell-off of shares ahead of the announcement. Market sentiment appears to be affected by concerns about Clover Health Investments, Corp.'s financial health and growth prospects.

24.02.2026 - CLOV Stock was down 6.5%

• Today's bearish movement in Clover Health's stock (CLOV) could be linked to a series of insider selling activities by top executives, such as CEO Jamie L. Reynoso and General Counsel Karen Soares. This may be perceived by the market as a lack of confidence in the company's future performance, resulting in a negative investor sentiment.
• Executives' automatic withholding of shares to cover tax obligations from RSU vesting might suggest potential cash flow issues or personal financial commitments, which could further affect investor confidence in the stock.
• In summary, insider selling paired with tax-related share withholding likely contributed to the stock's bearish performance today, as investors react to signs of potential internal issues within the company.

13.03.2026 - CLOV Stock was up 5.3%

• The bullish movement in CLOV's stock could be attributed to the positive sentiment generated by recent filings of beneficial ownership by key executives, including the VP of Finance, interim CFO, and CEO of Medicare Advantage.
• Disclosure of significant share ownership and RSUs by these executives indicates their confidence in the company's future performance, likely appealing to investors.
• The CEO of Medicare Advantage using vested shares to cover tax obligations demonstrates commitment to long-term growth, which could enhance investor trust and optimism in CLOV's prospects.
• The various ownership disclosures and transactions by key executives at Clover Health Investments probably played a role in today's bullish movement in CLOV's stock.